There are 2949 resources available
1715P - Plinabulin (Plin) is a more favorable option for the prevention of chemotherapy induced neutropenia (CIN) than pegfilgrastim (Peg) during the COVID-19 pandemic
Presenter: Douglas Blayney
Session: E-Poster Display
Resources:
Abstract
1716P - Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
Presenter: Christopher Jay
Session: E-Poster Display
Resources:
Abstract
1717P - Behavioral practices of cancer patients during COVID-19 pandemic: A Middle East and North Africa Study
Presenter: Abdul Rahman Jazieh
Session: E-Poster Display
Resources:
Abstract
1718P - A French experience on COVID-19 and cancer from an academic general hospital in Paris area
Presenter: Pierre Antoine Laurain
Session: E-Poster Display
Resources:
Abstract
1719P - Clinical characteristics and 28-day mortality among patients with solid cancers and COVID-19 in a tertiary hospital
Presenter: J. Carlos Tapia
Session: E-Poster Display
Resources:
Abstract
1720P - How do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium
Presenter: Concetta Elisa Onesti
Session: E-Poster Display
Resources:
Abstract
1721P - Prolonged positive SARS-CoV-2 RT-PCR in cancer outpatients requires specific reorganization of cancer centres
Presenter: Lorea Aguinaga
Session: E-Poster Display
Resources:
Abstract
1722P - Longitudinal analysis of biochemical and haematological features of cancer patients with COVID-19
Presenter: Ann Tivey
Session: E-Poster Display
Resources:
Abstract
1723P - Organizational challenges and oncological activity volumes during the SARS-CoV-2 epidemic peak in Verona, Italy
Presenter: Sara Merler
Session: E-Poster Display
Resources:
Abstract
1724P - Changes in the outpatient and inpatient clinic admissions during COVID-19 pandemic: Anticipating and mitigating risks for cancer patients
Presenter: Deniz Can Guven
Session: E-Poster Display
Resources:
Abstract